ARO-C3 clinical trials

A Phase 1/2a Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARO-C3 in Adult Healthy Volunteers and in Adult Patients With Complement-Mediated Renal Disease

This study is testing a new medicine called ARO-C3. It's for adults with a kidney problem caused by their immune system. Researchers want to see if the medicine is safe, how the body handles it, and if it helps with the kidney condition.